Meeting the highly ambitious 17 goals and 169 targets of the Sustainable Development Goals (SDGs) by 2030 and ensuring adequate response to global health crisis will require further scientific breakthroughs and strategic innovations.

Global health industries such as biopharmaceuticals, biotech, diagnostics, medical devices, vaccines, diagnostic imaging and data and digital medical industries and others have a fundamental role to play in contributing to the diverse treatment and prevention ecosystem of which they are part by working alongside public and private providers, health professionals, hospitals and clinics, laboratory services, and health insurers.

The Alliance is committed to delivering high-quality healthcare to people worldwide as well as safeguarding innovation and promoting access to innovation.